http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0203611-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16 |
| filingDate | 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17c67dde60ddffbe2058ca34d4940a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_930f0123311ced48948dcc24d418697d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5166ecc37428f215f05170256cc7f04f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c856081be5cf6e53ded8cf0e01871b28 |
| publicationDate | 2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0203611-A2 |
| titleOfInvention | 14,15-beta-methylene substituted androgens and their use in the manufacture of medicaments |
| abstract | The present invention relates to new steroids characterized by a 14b, 15b-cyclopropane ring and a 17a-hydroxymethyl group. In the compounds of formula (I) of the present invention, R 1 is O, (H, H), (H, OR), NOR, wherein R is hydrogen, C 1-6 alkyl, C 1-6 atom, R 2 is hydrogen or 1-6. szénatomosalkilcsoport; R3 is hydrogen; or R 3 is C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl, each of which may be optionally substituted by halogen; R 4 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl; R 5 is C 1-6 alkyl; R6 is hydrogen, halogen or C1-C4 alkyl; R 7 is hydrogen or C 1-6 alkyl; R8 is hydrogen, halogen, hydroxy, (C1-C6) alkoxy or (C1-C6) alkyl; R9 and R10 are independently hydrogen; or R 9 and R 10 are independently C 1-6 alkyl, C 2-6 alkenyl, C 3-6 cycloalkyl, C 5-6 cycloalkenyl or C 2-6 alkynyl optionally substituted with C 1-4 alkoxy or halogen ; R11 is hydrogen, SO3H, C1-C15 acyl; and the dashed lines indicate an optional bond, which may be a D4, D5 (10) or D11 double bond, or a D4,9 or D4,11 diene system. The steroids of the present invention are androgenic. They can be used in the manufacture of a male contraceptive and in the manufacture of a medicament for the treatment of androgen deficiency. SHE |
| priorityDate | 1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 165.